Clinical trial
Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances…
NCT00160147 · Solvay Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00160147 |
|---|---|
| Title | Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type |
| Official title | A Randomized, Double-Blind, Placebo-controlled, Efficacy, Safety, and Tolerability Study of Bifeprunox in the Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type |
| Intervention type | Drug |
| Interventions | bifeprunox, Placebo |
| Enrollment | 60 |
| Start date | Dec 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 9, 2015 |
| Countries | Czechia, Estonia, Israel, Poland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: